Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1996 May 28;93(11):5235–5240. doi: 10.1073/pnas.93.11.5235

Traumatic brain damage prevented by the non-N-methyl-D-aspartate antagonist 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo[f] quinoxaline.

H Bernert 1, L Turski 1
PMCID: PMC39228  PMID: 8643559

Abstract

The mechanisms of neuronal degeneration following traumatic head injury are not well understood and no adequate treatment is currently available for the prevention of traumatic brain damage in humans. Traumatic head injury leads to primary (at impact) and secondary (distant) damage to the brain. Mechanical percussion of the rat cortex mimics primary damage seen after traumatic head injury in humans; no animal model mimicking the secondary damage following traumatic head injury has yet been established. Rats subjected to percussion trauma of the cortex showed primary damage in the cortex and secondary damage in the hippocampus. Morphometric analysis demonstrated that both cortical and hippocampal damage was mitigated by pretreatment with either the N-methyl-D-aspartate (NMDA) antagonist 3-((+/-)- 2-carboxypiperazin-4-yl)-propyl-1-phosphonate (CPP) or the non-NMDA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline (NBQX). Neither treatment prevented primary damage in the cortex when therapy was started after trauma. Surprisingly, delayed treatment of rats with NBQX, but not with CPP, beginning between 1 and 7 hr after trauma prevented hippocampal damage. No protection was seen when therapy with NBQX was started 10 hr after trauma. These data indicate that both NMDA- and non-NMDA-dependent mechanisms contribute to the development of primary damage in the cortex, whereas non-NMDA mechanisms are involved in the evolution of secondary damage in the hippocampus in rats subjected to traumatic head injury. The wide therapeutic time-window documented for NBQX suggests that antagonism at non-NMDA receptors may offer a novel therapeutic approach for preventing deterioration of the brain after head injury.

Full text

PDF
5235

Images in this article

5236Fig. 1
on p.5236
5238Fig. 3
on p.5238

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cruz-Orive L. M., Weibel E. R. Recent stereological methods for cell biology: a brief survey. Am J Physiol. 1990 Apr;258(4 Pt 1):L148–L156. doi: 10.1152/ajplung.1990.258.4.L148. [DOI] [PubMed] [Google Scholar]
  2. Faden A. I., Demediuk P., Panter S. S., Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science. 1989 May 19;244(4906):798–800. doi: 10.1126/science.2567056. [DOI] [PubMed] [Google Scholar]
  3. Feeney D. M., Boyeson M. G., Linn R. T., Murray H. M., Dail W. G. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res. 1981 Apr 27;211(1):67–77. doi: 10.1016/0006-8993(81)90067-6. [DOI] [PubMed] [Google Scholar]
  4. Fink R. P., Heimer L. Two methods for selective silver impregnation of degenerating axons and their synaptic endings in the central nervous system. Brain Res. 1967 Apr;4(4):369–374. doi: 10.1016/0006-8993(67)90166-7. [DOI] [PubMed] [Google Scholar]
  5. Gennarelli T. A. Emergency department management of head injuries. Emerg Med Clin North Am. 1984 Nov;2(4):749–760. [PubMed] [Google Scholar]
  6. Goldstein M. Traumatic brain injury: a silent epidemic. Ann Neurol. 1990 Mar;27(3):327–327. doi: 10.1002/ana.410270315. [DOI] [PubMed] [Google Scholar]
  7. Gundersen H. J., Bagger P., Bendtsen T. F., Evans S. M., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J. R., Pakkenberg B. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS. 1988 Oct;96(10):857–881. doi: 10.1111/j.1699-0463.1988.tb00954.x. [DOI] [PubMed] [Google Scholar]
  8. Gundersen H. J., Jensen E. B. The efficiency of systematic sampling in stereology and its prediction. J Microsc. 1987 Sep;147(Pt 3):229–263. doi: 10.1111/j.1365-2818.1987.tb02837.x. [DOI] [PubMed] [Google Scholar]
  9. Hu B. R., Wieloch T. Persistent translocation of Ca2+/calmodulin-dependent protein kinase II to synaptic junctions in the vulnerable hippocampal CA1 region following transient ischemia. J Neurochem. 1995 Jan;64(1):277–284. doi: 10.1046/j.1471-4159.1995.64010277.x. [DOI] [PubMed] [Google Scholar]
  10. Ikonomidou C., Turski L. Excitotoxicity and neurodegenerative diseases. Curr Opin Neurol. 1995 Dec;8(6):487–497. doi: 10.1097/00019052-199512000-00017. [DOI] [PubMed] [Google Scholar]
  11. Klockgether T., Turski L., Schwarz M., Sontag K. H., Lehmann J. Paradoxical convulsant action of a novel non-competitive N-methyl-D-aspartate (NMDA) antagonist, tiletamine. Brain Res. 1988 Oct 4;461(2):343–348. doi: 10.1016/0006-8993(88)90265-x. [DOI] [PubMed] [Google Scholar]
  12. Lehmann J., Schneider J., McPherson S., Murphy D. E., Bernard P., Tsai C., Bennett D. A., Pastor G., Steel D. J., Boehm C. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo. J Pharmacol Exp Ther. 1987 Mar;240(3):737–746. [PubMed] [Google Scholar]
  13. Li H., Buchan A. M. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury. J Cereb Blood Flow Metab. 1993 Nov;13(6):933–939. doi: 10.1038/jcbfm.1993.116. [DOI] [PubMed] [Google Scholar]
  14. McGlade-McCulloh E., Yamamoto H., Tan S. E., Brickey D. A., Soderling T. R. Phosphorylation and regulation of glutamate receptors by calcium/calmodulin-dependent protein kinase II. Nature. 1993 Apr 15;362(6421):640–642. doi: 10.1038/362640a0. [DOI] [PubMed] [Google Scholar]
  15. Mcintosh T. K., Vink R., Soares H., Hayes R., Simon R. Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury. J Neurotrauma. 1989 Winter;6(4):247–259. doi: 10.1089/neu.1989.6.247. [DOI] [PubMed] [Google Scholar]
  16. Papaioannou V. E., Fox J. G. Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci. 1993 Apr;43(2):189–192. [PubMed] [Google Scholar]
  17. Pellegrini-Giampietro D. E., Zukin R. S., Bennett M. V., Cho S., Pulsinelli W. A. Switch in glutamate receptor subunit gene expression in CA1 subfield of hippocampus following global ischemia in rats. Proc Natl Acad Sci U S A. 1992 Nov 1;89(21):10499–10503. doi: 10.1073/pnas.89.21.10499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sheardown M. J., Suzdak P. D., Nordholm L. AMPA, but not NMDA, receptor antagonism is neuroprotective in gerbil global ischaemia, even when delayed 24 h. Eur J Pharmacol. 1993 Jun 4;236(3):347–353. doi: 10.1016/0014-2999(93)90470-3. [DOI] [PubMed] [Google Scholar]
  19. West M. J., Gundersen H. J. Unbiased stereological estimation of the number of neurons in the human hippocampus. J Comp Neurol. 1990 Jun 1;296(1):1–22. doi: 10.1002/cne.902960102. [DOI] [PubMed] [Google Scholar]
  20. Wrathall J. R., Bouzoukis J., Choiniere D. Effect of kynurenate on functional deficits resulting from traumatic spinal cord injury. Eur J Pharmacol. 1992 Aug 6;218(2-3):273–281. doi: 10.1016/0014-2999(92)90179-8. [DOI] [PubMed] [Google Scholar]
  21. Wrathall J. R., Teng Y. D., Choiniere D., Mundt D. J. Evidence that local non-NMDA receptors contribute to functional deficits in contusive spinal cord injury. Brain Res. 1992 Jul 17;586(1):140–143. doi: 10.1016/0006-8993(92)91384-q. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES